|
|
||||||||
1 iCAPTURE4 Centre, Vancouver Vascular Biology Research Centre, St. Paul's Hospital, University of British Columbia, Vancouver V6Z 1Y6; and 2 Department of Cardiac Surgery, University of British Columbia, Vancouver, British Columbia, V5Z 4E3 Canada
The human saphenous vein (HSV) is the most widely used graft in coronary artery revascularization procedures and is susceptible to spasm perioperatively. The aim of this study is to elucidate the mechanism(s) of agonist-induced excitation-contraction coupling in this vessel. Isometric contraction experiments were combined with in situ smooth muscle intracellular Ca2+ concentration ([Ca2+]i) imaging by confocal microscopy of intact undistended HSV segments during activation with phenylephrine (PE; 50 µM). Stimulation with PE produced a sustained contraction. Preincubation with 5 µM nifedipine, a blocker of the L-type voltage-operated Ca2+ channel, or 50 µM SKF-96365, a blocker of both the voltage- and receptor-operated channels, reduced force generation by 25-30%. Ca2+ imaging revealed that PE elicited only a transient rise in [Ca2+]i, suggesting that Ca2+ plays only a minor role. However, a requirement for basal Ca2+ levels was demonstrated when PE contractions could not be maintained in Ca2+-free medium. In light of the transient Ca2+ response, it appears that signals other than Ca2+ must maintain the tonic contraction elicited by PE, such as those that sensitize the myofilaments to Ca2+. Application of HA-1077 (a Rho kinase inhibitor) at the peak of the contraction completely abolished the plateau phase of the response, whereas application of genistein (a tyrosine kinase inhibitor) reduced this phase by ~50%. The foregoing results suggest that, whereas the transient Ca2+ signal can contribute to the development of force, maintenance of the plateau phase of the PE contraction in the HSV is the result of myofilament Ca2+ sensitization by Rho kinase and tyrosine phosphorylation. The elucidation of the mechanisms of excitation-contraction coupling in the HSV may be useful for the development of therapeutic strategies for the alleviation of vein graft spasm.
calcium; Rho kinase; tyrosine kinase; smooth muscle;
1-adrenergic receptor agonist
This article has been cited by other articles:
![]() |
J. M. Dai, K.-H. Kuo, J. M. Leo, P. D. Pare, C. van Breemen, and C.-H. Lee Acetylcholine-Induced Asynchronous Calcium Waves in Intact Human Bronchial Muscle Bundle Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 600 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zacharia, J. Zhang, and W. G. Wier Ca2+ signaling in mouse mesenteric small arteries: myogenic tone and adrenergic vasoconstriction Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1523 - H1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W.Y. Chung, P. Rauniyar, H. Luo, Y. N. Hsiang, C. van Breemen, and E. B. Okon Pharmacologic relaxation of vein grafts is beneficial compared with pressure distention caused by upregulation of endothelial nitric oxide synthase and nitric oxide production J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 925 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Okon, A. W.Y. Chung, P. Rauniyar, E. Padilla, T. Tejerina, B. M. McManus, H. Luo, and C. van Breemen Compromised Arterial Function in Human Type 2 Diabetic Patients Diabetes, August 1, 2005; 54(8): 2415 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Diebolt, L. Germain, F. A. Auger, and R. Andriantsitohaina Mechanism of potentiation by polyphenols of contraction in human vein-engineered media Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2918 - H2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G Lambert and G. D Thomas {alpha}-Adrenoceptor constrictor responses and their modulation in slow-twitch and fast-twitch mouse skeletal muscle J. Physiol., March 15, 2005; 563(3): 821 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Luykenaar, S. E. Brett, B. N. Wu, W. B. Wiehler, and D. G. Welsh Pyrimidine nucleotides suppress KDR currents and depolarize rat cerebral arteries by activating Rho kinase Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1088 - H1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Okon, M. J. Millar, C. M. Crowley, J. G. Bashir, R. C. Cook, Y. N. Hsiang, B. McManus, and C. van Breemen Effect of moderate pressure distention on the human saphenous vein vasomotor function Ann. Thorac. Surg., January 1, 2004; 77(1): 108 - 114. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |